Hims & Hers Health (NYSE:HIMS) has launched generic semaglutide in Canada following a key patent lapse, marking its first GLP-1 offering outside the United States. Hims & Hers Health is also expanding ...
Stocktwits on MSN
HIMS stock eyes breakout week: Eight new partners fuel push to build an all-in-one health platform
Hims & Hers added eight new partners, expanding its Benefits program across fitness, nutrition, glucose monitoring, women's health and sleep. ・The company recently launched generic Semaglutide in ...
Stocktwits on MSN
HIMS stock slides overnight: CEO sees healthcare potential in Anthropic's AI leap as Lilly, WeightWatchers turn up the heat
CEO Andrew Dudum called Anthropic's latest AI breakthrough "transformative" for population health, saying AI is moving "from super helpful to superhuman." ・Hims is building a healthcare super app, ...
Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers ...
HIMS expands its integrated telehealth ecosystem with a new weight-loss membership and a planned Eucalyptus acquisition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results